Brian Onyango

Ask VT AI
View News Summary
  • Novo Nordisk expands access to weight-loss drug Wegovy through telehealth partnerships, offering discounted rates as compounded GLP-1 alternatives become less available.
  • Zebra Technologies cuts 2025 outlook amid tariffs, despite strong Q1 results.
  • Kobe Bryant mural vandalized amid street art feud, sparking outrage and restoration efforts.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Novo Nordisk expands access to weight-loss drug Wegovy through telehealth partnerships, offering discounted rates as compounded GLP-1 alternatives become less available.
  • Zebra Technologies cuts 2025 outlook amid tariffs, despite strong Q1 results.
  • Kobe Bryant mural vandalized amid street art feud, sparking outrage and restoration efforts.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Brian Onyango